Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Other Working Capital Changes (2020 - 2025)

Foghorn Therapeutics (FHTX) has 6 years of Other Working Capital Changes data on record, last reported at $14.9 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 869.42% year-over-year to $14.9 million; the TTM value through Dec 2025 reached -$19.2 million, down 141.82%, while the annual FY2025 figure was -$6.7 million, 15.1% up from the prior year.
  • Other Working Capital Changes reached $14.9 million in Q4 2025 per FHTX's latest filing, up from -$19.7 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $336.8 million in Q4 2021 and bottomed at -$32.9 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $13.4 million, with a median of -$1.8 million recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: soared 134280.48% in 2021, then tumbled 512.59% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at $336.8 million in 2021, then tumbled by 101.75% to -$5.9 million in 2022, then crashed by 456.26% to -$32.9 million in 2023, then skyrocketed by 94.1% to -$1.9 million in 2024, then skyrocketed by 869.42% to $14.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $14.9 million in Q4 2025, -$19.7 million in Q3 2025, and -$8.5 million in Q2 2025.